Market Research Report
Asia Pacific Orthopedic Biomaterials Market (2019-2025)
|Published by||KBV Research||Product code||914081|
|Published||Content info||74 Pages
Delivery time: 1-2 business days
|Asia Pacific Orthopedic Biomaterials Market (2019-2025)|
|Published: September 30, 2019||Content info: 74 Pages||
The Asia Pacific Orthopedic Biomaterials Market would witness market growth of 11.5% CAGR during the forecast period (2019-2025). Asia-Pacific is the most rapidly growing industry for orthopedic biomaterials for the large population and the expansion of the industry in medical therapy in the region. The growing consumer awareness and enhanced culture of India, and China, growing economies are a boost to market growth. Also, the improved economy in the region preserves the potential that this market continues to expand and creates opportunities during the forecast period in orthopedic biomaterials market.
The radical shift from conventional invasive to minimally invasive orthopedic surgeries or disorders has a positive effect on market growth. Furthermore, the advent of innovative and personalized 3D printed implants with the incorporation of assistive imaging techniques, like magnetic resonance imaging and computed tomography employed to create surgical designs. These designs are coupled with the presence of advanced, robotically-assisted surgical tools, which is increasing the overall patient acceptance of these increased orthopedic prostheses. It can be thus concluded that the budding market landscape for orthopedic implants would also boost the overall orthopedic biomaterials market.
Based on Material Type, the market is segmented into Emergency Care, Short-Term Stabilization, Trauma Care, Acute care surgery and Other Conditions. Based on Application, the market is segmented into Orthopedic Implants, Joint Replacements, Bio-resorbable Tissue Fixation, Orthobiologics and Visco Supplementation. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Australia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Zimmer Biomet Holdings, Inc., Stryker Corporation, Victrex PLC (Invibio Ltd.), Globus Medical, Inc., CAM Bioceramics B.V., Heraeus Holding GmbH, Exactech, Inc., Collagen Matrix, Inc., Evonik Industries AG and Koninklijke DSM N.V. (DSM Biomedical B.V.).